IceCure Medical (ICCM) Competitors $1.16 -0.10 (-7.94%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$1.20 +0.05 (+3.88%) As of 04:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICCM vs. ZIMV, SNWV, PDEX, NVRO, LUNG, NYXH, RCEL, CVRX, ELMD, and INGNShould you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include ZimVie (ZIMV), SANUWAVE Health (SNWV), Pro-Dex (PDEX), Nevro (NVRO), Pulmonx (LUNG), Nyxoah (NYXH), AVITA Medical (RCEL), CVRx (CVRX), Electromed (ELMD), and Inogen (INGN). These companies are all part of the "medical equipment" industry. IceCure Medical vs. ZimVie SANUWAVE Health Pro-Dex Nevro Pulmonx Nyxoah AVITA Medical CVRx Electromed Inogen IceCure Medical (NASDAQ:ICCM) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and analyst recommendations. Do insiders & institutionals believe in ICCM or ZIMV? 0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 3.0% of ZimVie shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend ICCM or ZIMV? IceCure Medical currently has a consensus target price of $2.50, suggesting a potential upside of 115.52%. ZimVie has a consensus target price of $19.50, suggesting a potential upside of 115.71%. Given ZimVie's higher probable upside, analysts plainly believe ZimVie is more favorable than IceCure Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50ZimVie 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor ICCM or ZIMV? IceCure Medical received 20 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 96.30% of users gave IceCure Medical an outperform vote while only 28.57% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformIceCure MedicalOutperform Votes2696.30% Underperform Votes13.70%ZimVieOutperform Votes628.57% Underperform Votes1571.43% Is ICCM or ZIMV more profitable? ZimVie has a net margin of -77.31% compared to IceCure Medical's net margin of -376.85%. ZimVie's return on equity of 2.90% beat IceCure Medical's return on equity.Company Net Margins Return on Equity Return on Assets IceCure Medical-376.85% -124.44% -87.70% ZimVie -77.31%2.90%1.17% Which has more volatility and risk, ICCM or ZIMV? IceCure Medical has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500. Does the media prefer ICCM or ZIMV? In the previous week, IceCure Medical had 2 more articles in the media than ZimVie. MarketBeat recorded 4 mentions for IceCure Medical and 2 mentions for ZimVie. ZimVie's average media sentiment score of 1.20 beat IceCure Medical's score of 0.58 indicating that ZimVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IceCure Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ZimVie 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, ICCM or ZIMV? IceCure Medical has higher earnings, but lower revenue than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIceCure Medical$3.29M19.56-$14.65M-$0.30-3.87ZimVie$449.75M0.56-$393.28M-$0.95-9.52 SummaryZimVie beats IceCure Medical on 10 of the 18 factors compared between the two stocks. Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICCM vs. The Competition Export to ExcelMetricIceCure MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$64.38M$4.33B$5.53B$7.93BDividend YieldN/A39.93%5.11%4.22%P/E Ratio-4.0030.0322.5118.54Price / Sales19.5655.31397.62103.30Price / CashN/A51.0838.1834.62Price / Book4.306.056.734.25Net Income-$14.65M$68.71M$3.22B$248.18M7 Day Performance-3.33%-0.24%1.38%1.03%1 Month Performance-6.45%-2.90%2.79%2.70%1 Year Performance-1.69%21.00%15.41%4.05% IceCure Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICCMIceCure Medical2.7159 of 5 stars$1.16-7.9%$2.50+115.5%-0.9%$64.38M$3.29M-4.0060Short Interest ↓Gap UpZIMVZimVie2.4826 of 5 stars$9.31-1.4%$19.50+109.5%-41.7%$259.26M$449.75M-0.712,700Positive NewsSNWVSANUWAVE HealthN/A$27.40-3.8%N/AN/A$234.24M$32.63M-7.0340High Trading VolumePDEXPro-Dex1.4251 of 5 stars$69.00+6.3%$52.00-24.6%+261.6%$225.01M$61.00M34.33140Short Interest ↑News CoveragePositive NewsHigh Trading VolumeNVRONevro0.1892 of 5 stars$5.85+0.1%$5.36-8.3%-43.8%$224.32M$408.52M-3.091,090Upcoming EarningsAnalyst ForecastLUNGPulmonx3.731 of 5 stars$5.19-0.2%$12.75+145.7%-51.2%$208.88M$83.79M-3.60250Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageGap UpNYXHNyxoah2.2831 of 5 stars$6.01+2.4%$14.50+141.3%-36.6%$204.70M$4.52M-3.21110RCELAVITA Medical1.6879 of 5 stars$10.25+1.8%$17.25+68.3%+8.0%$198.26M$64.25M-4.29130News CoverageGap DownCVRXCVRx3.1145 of 5 stars$7.52+11.7%$16.83+123.8%-28.0%$195.79M$51.29M-2.80160Upcoming EarningsShort Interest ↓News CoveragePositive NewsHigh Trading VolumeELMDElectromed0.6146 of 5 stars$22.87-0.8%$38.00+66.2%+30.6%$195.70M$59.63M30.49160Analyst UpgradePositive NewsINGNInogen2.5599 of 5 stars$7.27-0.1%$7.00-3.7%+0.1%$195.47M$335.71M-3.231,030Upcoming EarningsShort Interest ↑Positive News Related Companies and Tools Related Companies ZIMV Alternatives SNWV Alternatives PDEX Alternatives NVRO Alternatives LUNG Alternatives NYXH Alternatives RCEL Alternatives CVRX Alternatives ELMD Alternatives INGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICCM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.